John Bencich
Chief Executive Officer at ACHIEVE LIFE SCIENCES, INC.
Net worth: 434 666 $ as of 2024-03-30
Profile
John A.
Bencich is currently the Director, Chief Executive & Financial Officer at Achieve Life Sciences, Inc. He previously worked as the Finance Director & Controller at Onyx Software Corp.
from 2004 to 2007.
Prior to that, he was the General Manager at Ernst & Young LLP from 1999 to 2004.
From 2007 to 2010, he served as the Chief Financial Officer, Treasurer & VP at Emergent Product Development Seattle.
In 2011, he was the Chief Financial Officer at Allozyne, Inc. From 2012 to 2014, he held the position of Chief Financial Officer at Integrated Diagnostics, Inc. Lastly, from 2014 to 2017, he worked as the Chief Financial Officer & Vice President at OncoGenex Pharmaceuticals, Inc. Mr. Bencich obtained an MBA from Seattle University in 2011 and an undergraduate degree from the University of San Diego in 1999.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-18 | 95,636 ( 0.28% ) | 434 666 $ | 2024-03-30 |
John Bencich active positions
| Companies | Position | Start |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Chief Executive Officer | 2020-09-27 |
Former positions of John Bencich
| Companies | Position | End |
|---|---|---|
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Director of Finance/CFO | 2017-06-30 |
Integrated Diagnostics, Inc.
 Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Director of Finance/CFO | 2014-07-31 |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Allozyne, Inc. operates as a biotechnology company that develops and manufactures pharmaceutical products. The firm focuses on manufacture of protein therapeutics for the medical need in autoimmune diseases and cancer. The company was founded by David A. Tirrell, Deepshikha Datta, and William A. Goddard, III in March 2004 and is headquartered in Seattle, WA. | Director of Finance/CFO | 2012-07-31 |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Director of Finance/CFO | 2010-09-30 |
Onyx Software Corp.
 Onyx Software Corp. Packaged SoftwareTechnology Services Onyx Software Corp. provides enterprise customer software management solutions that combine customer management, process management, and performance management technologies. It helps organizations more effectively to acquire, service, manage, and maintain customer and partner relationships. The company was founded in 1994 and is headquartered in Kirkland, WA | Director of Finance/CFO | 2007-03-31 |
Training of John Bencich
| University of San Diego | Undergraduate Degree |
| Seattle University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Onyx Software Corp.
Onyx Software Corp. Packaged SoftwareTechnology Services Onyx Software Corp. provides enterprise customer software management solutions that combine customer management, process management, and performance management technologies. It helps organizations more effectively to acquire, service, manage, and maintain customer and partner relationships. The company was founded in 1994 and is headquartered in Kirkland, WA | Technology Services |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Allozyne, Inc.
Allozyne, Inc. Medical SpecialtiesHealth Technology Allozyne, Inc. operates as a biotechnology company that develops and manufactures pharmaceutical products. The firm focuses on manufacture of protein therapeutics for the medical need in autoimmune diseases and cancer. The company was founded by David A. Tirrell, Deepshikha Datta, and William A. Goddard, III in March 2004 and is headquartered in Seattle, WA. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
Integrated Diagnostics, Inc.
Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Health Services |
- Stock Market
- Insiders
- John Bencich
